Left ventricular hypertrophy and ventricular tachyarrhythmia: the role of biomarkers

HIGHLIGHTS

  • who: Ljuba Bacharova and collaborators from the National Institute for Cardiovascular Diseases, , Faculty of Medicine, Comenius University in, , have published the article: Left Ventricular Hypertrophy and Ventricular Tachyarrhythmia: The Role of Biomarkers, in the Journal: (JOURNAL)
  • what: The aim of this paper was to review the Int. The research is now focused on new promising biomarkers and their implications for diagnostics and focused therapy.

SUMMARY

    Left ventricular hypertrophy (LVH) detected by ECG and imaging methods is an important cardiovascular risk factor associated with increased mortality and morbidity, the most dangerous life . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?